Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

Meghan C. Thompson; Rosemary A. Harrup; Catherine C. Coombs; Lindsey E. Roeker; Jeffrey J. Pu; Michael Y. Choi; Paul M. Barr; John N. Allan; Martin Simkovi; Lori Leslie; Joanna Rhodes; Elise A. Chong; Manali Kamdar; Alan Skarbnik; Frederick Lansigan; Brittany McCall; Khalid Saja; Martin J. S. Dyer; Harriet S. Walter; Marcus Lefebure; Maria Thadani-Mulero; Michelle Boyer; Juliana Biondo; Kavita Sail; Beenish S. Manzoor; Richard Furman; Kurt S. Bantilan; Andre Goy; Tatyana Feldman; Dominic Labella; Stephen J. Schuster; Jae Park; Lia Palomba; Andrew Zelenetz; Toby A. Eyre; Arnon P. Kater; John F. Seymour; Anthony R. Mato

doi:https://doi.org/10.1182/bloodadvances.2022007812

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

Meghan C. Thompson, Rosemary A. Harrup, Catherine C. Coombs, Lindsey E. Roeker, Jeffrey J. Pu, Michael Y. Choi, Paul M. Barr, John N. Allan, Martin Simkovi, Lori Leslie, Joanna Rhodes, Elise A. Chong, Manali Kamdar, Alan Skarbnik, Frederick Lansigan, Brittany McCall, Khalid Saja, Martin J. S. Dyer, Harriet S. Walter, Marcus LefebureMaria Thadani-Mulero, Michelle Boyer, Juliana Biondo, Kavita Sail, Beenish S. Manzoor, Richard Furman, Kurt S. Bantilan, Andre Goy, Tatyana Feldman, Dominic Labella, Stephen J. Schuster, Jae Park, Lia Palomba, Andrew Zelenetz, Toby A. Eyre, Arnon P. Kater, John F. Seymour, Anthony R. Mato

Research output: Contribution to journal › Comment/Letter to the editor › Academic

23 Citations (Scopus)

Original language	English
Pages (from-to)	4553-4557
Number of pages	5
Journal	Blood advances
Volume	6
Issue number	15
DOIs	https://doi.org/10.1182/bloodadvances.2022007812
Publication status	Published - 9 Aug 2022

Access to Document

https://doi.org/10.1182/bloodadvances.2022007812

Cite this

Thompson, M. C., Harrup, R. A., Coombs, C. C., Roeker, L. E., Pu, J. J., Choi, M. Y., Barr, P. M., Allan, J. N., Simkovi, M., Leslie, L., Rhodes, J., Chong, E. A., Kamdar, M., Skarbnik, A., Lansigan, F., McCall, B., Saja, K., Dyer, M. J. S., Walter, H. S., ... Mato, A. R. (2022). Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen. Blood advances, 6(15), 4553-4557. https://doi.org/10.1182/bloodadvances.2022007812

@article{aa202faa9507405199bc4e7d0c858253,

title = "Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen",

author = "Thompson, {Meghan C.} and Harrup, {Rosemary A.} and Coombs, {Catherine C.} and Roeker, {Lindsey E.} and Pu, {Jeffrey J.} and Choi, {Michael Y.} and Barr, {Paul M.} and Allan, {John N.} and Martin Simkovi and Lori Leslie and Joanna Rhodes and Chong, {Elise A.} and Manali Kamdar and Alan Skarbnik and Frederick Lansigan and Brittany McCall and Khalid Saja and Dyer, {Martin J. S.} and Walter, {Harriet S.} and Marcus Lefebure and Maria Thadani-Mulero and Michelle Boyer and Juliana Biondo and Kavita Sail and Manzoor, {Beenish S.} and Richard Furman and Bantilan, {Kurt S.} and Andre Goy and Tatyana Feldman and Dominic Labella and Schuster, {Stephen J.} and Jae Park and Lia Palomba and Andrew Zelenetz and Eyre, {Toby A.} and Kater, {Arnon P.} and Seymour, {John F.} and Mato, {Anthony R.}",

note = "Funding Information: Acknowledgments: This research was supported in part by The Lymphoma Foundation (M.C.T.). T.A.E. recognizes support from the Oxford NIHR Biomedical Research Centre.",

year = "2022",

month = aug,

day = "9",

doi = "https://doi.org/10.1182/bloodadvances.2022007812",

language = "English",

volume = "6",

pages = "4553--4557",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "15",

}

Thompson, MC, Harrup, RA, Coombs, CC, Roeker, LE, Pu, JJ, Choi, MY, Barr, PM, Allan, JN, Simkovi, M, Leslie, L, Rhodes, J, Chong, EA, Kamdar, M, Skarbnik, A, Lansigan, F, McCall, B, Saja, K, Dyer, MJS, Walter, HS, Lefebure, M, Thadani-Mulero, M, Boyer, M, Biondo, J, Sail, K, Manzoor, BS, Furman, R, Bantilan, KS, Goy, A, Feldman, T, Labella, D, Schuster, SJ, Park, J, Palomba, L, Zelenetz, A, Eyre, TA, Kater, AP, Seymour, JF & Mato, AR 2022, 'Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen', Blood advances, vol. 6, no. 15, pp. 4553-4557. https://doi.org/10.1182/bloodadvances.2022007812

TY - JOUR

T1 - Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

AU - Thompson, Meghan C.

AU - Harrup, Rosemary A.

AU - Coombs, Catherine C.

AU - Roeker, Lindsey E.

AU - Pu, Jeffrey J.

AU - Choi, Michael Y.

AU - Barr, Paul M.

AU - Allan, John N.

AU - Simkovi, Martin

AU - Leslie, Lori

AU - Rhodes, Joanna

AU - Chong, Elise A.

AU - Kamdar, Manali

AU - Skarbnik, Alan

AU - Lansigan, Frederick

AU - McCall, Brittany

AU - Saja, Khalid

AU - Dyer, Martin J. S.

AU - Walter, Harriet S.

AU - Lefebure, Marcus

AU - Thadani-Mulero, Maria

AU - Boyer, Michelle

AU - Biondo, Juliana

AU - Sail, Kavita

AU - Manzoor, Beenish S.

AU - Furman, Richard

AU - Bantilan, Kurt S.

AU - Goy, Andre

AU - Feldman, Tatyana

AU - Labella, Dominic

AU - Schuster, Stephen J.

AU - Park, Jae

AU - Palomba, Lia

AU - Zelenetz, Andrew

AU - Eyre, Toby A.

AU - Kater, Arnon P.

AU - Seymour, John F.

AU - Mato, Anthony R.

N1 - Funding Information: Acknowledgments: This research was supported in part by The Lymphoma Foundation (M.C.T.). T.A.E. recognizes support from the Oxford NIHR Biomedical Research Centre.

PY - 2022/8/9

Y1 - 2022/8/9

UR - http://www.scopus.com/inward/record.url?scp=85135485099&partnerID=8YFLogxK

U2 - https://doi.org/10.1182/bloodadvances.2022007812

DO - https://doi.org/10.1182/bloodadvances.2022007812

M3 - Comment/Letter to the editor

C2 - 35736670

SN - 2473-9529

VL - 6

SP - 4553

EP - 4557

JO - Blood advances

JF - Blood advances

IS - 15

ER -

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

Access to Document

Other files and links

Cite this